healthcare it adoption, function, value & beyond february ... · healthcare it adoption, function,...

49
Healthcare IT Adoption, Function, Value & Beyond February 29, 2016 John H. Daniels, CNM, FACHE, FHIMSS, CPHIMS Global Vice President, HIMSS Analytics

Upload: others

Post on 26-Aug-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

  • Healthcare IT Adoption, Function, Value & Beyond

    February 29, 2016 John H. Daniels, CNM, FACHE, FHIMSS, CPHIMS

    Global Vice President, HIMSS Analytics

  • Agenda • Challenge • Approach • Progress • Benefits realization • Q&A

  • Learning Objectives • Recognize the clinical and business value that can be achieved from

    the use of information technology in care delivery processes • Recognize stages of electronic medical record functionalities towards

    improving care delivery processes • Identify the next great challenge to multi-stakeholder continuity of

    care and the recommended strategic approach to address the challenge

  • 98K+ patients die annually in the United States

    due to medical errors!!

    Why?

    Lack of Relevant Information

    Kohn, Linda T. To Err Is Human: Building a Safer Health System. Washington, D.C.: National Academy Press, 2000.

  • Pre

    ss

    urr

    ing

    /

    Ove

    rlo

    ad

    Medical Knowledge

    Automate to optimize clinical decision making

    Chart1

    0

    0

    0

    0

    Series 1

    Medical Knowledge

    Pressurring / Overload

    Sheet1

    Series 1Series 2

    To resize chart data range, drag lower right corner of range.

  • Information technology is a MUST Using information technology, we can

    help make healthcare …

    Crossing the quality chasm: A new health system for the 21st century. (2001). Washington, D.C.: National Academy Press.

  • Ultimate Goal

    Ensure the most relevant

    information is available to the

    decision maker at the right place

    and at the right time

  • How can we do this?

  • Shared Vision

    Better health through Information Technology

  • Global HIMSS Analytics EMR Adoption ModelSM

    N = 5439 N = 5449

    Complete EMR, Data Analytics to Improve Care

    Physician documentation (templates), full CDSS, Closed loop medication administration

    Full R-PACS

    CPOE, Clinical Decision Support (clinical protocols)

    Clinical documentation, CDSS (error checking)

    CDR, Controlled Medical Vocabulary, CDS, HIE capable

    Ancillaries - Lab, Rad, Pharmacy - All Installed

    All Three Ancillaries Not Installed

    1.1%

    4.0%

    6.1%

    12.3%

    46.3%

    13.7%

    6.6%

    10.0%

    3.4%

    16.5%

    29.5%

    14.5%

    23.9%

    5.3%

    2.5%

    4.4%

    2011 Q2 2014 Q3

    Data from HIMSS ® Database ©2015 HIMSS

    … 7 Stages that lead to the

    Highest Quality in Patient Care

    Progressively sophisticated model …

  • HIMSS’ contribution to the vision • Thought leadership

    – Quality, Safety, Efficiency improvements • To reflect the market

    – Where are the current trends • To inform government policy

    – Contribute to national eHealth strategies – Used by governments for policy formulation

    • To “drive the market” – Useful roadmap for C-suite, governance boards,

    & policy makers

  • It takes time to make “significant” national progress

  • 20.4% 17.4%

    40.0%

    18.7%

    3.1% 0.5% 0.1% 0.0%

    0 1 2 3 4 5 6 7EMRAM Stage

    2006

  • 19.3%

    14.0%

    37.2%

    25.1%

    2.2% 1.4% 0.8% 0.0%

    0 1 2 3 4 5 6 7EMRAM Stage

    2007

  • 15.6% 11.5%

    31.4% 35.7%

    2.5% 2.5% 0.5% 0.3%

    0 1 2 3 4 5 6 7EMRAM Stage

    2008

  • 11.5% 7.2%

    16.9%

    7.4% 3.8%

    1.6% 0.7%

    0 1 2 3 4 5 6 7EMRAM Stage

    50.9%

    2009

  • 10.1% 7.1%

    14.6% 10.5%

    4.5% 3.2% 1.0%

    0 1 2 3 4 5 6 7EMRAM Stage

    2010

    49.0%

  • 9.0% 5.7%

    12.4%

    44.9%

    13.2% 8.4%

    5.2% 1.2%

    0 1 2 3 4 5 6 7EMRAM Stage

    2011

  • 8.4% 4.3%

    10.7%

    38.3%

    14.2% 14.0%

    8.2%

    1.9%

    0 1 2 3 4 5 6 7EMRAM Stage

    2012

  • 5.8% 3.3%

    7.6%

    30.3%

    15.5%

    22.0%

    12.5%

    2.9%

    0 1 2 3 4 5 6 7EMRAM Stage

    2013

  • 3.8% 2.0% 5.1%

    21.0%

    14.0%

    32.7%

    17.9%

    3.6%

    0 1 2 3 4 5 6 7EMRAM Stage

    2014

  • 2.1% 1.7% 2.6%

    16.4%

    10.1%

    35.9%

    27.1%

    4.2%

    0 1 2 3 4 5 6 7EMRAM Stage

    2015

  • EMR Adoption ModelSM (2006-2015) United States

    Stage 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

    Stage 7 0.0% 0.0% 0.3% 0.7% 1.0% 1.2% 1.9% 2.9% 3.6% 4.2%

    Stage 6 0.1% 0.8% 0.5% 1.6% 3.2% 5.2% 8.2% 12.5% 17.9% 27.1%

    Stage 5 0.5% 1.4% 2.5% 3.8% 4.5% 8.4% 14.0% 22.0% 32.8% 35.9%

    Stage 4 3.1% 2.2% 2.5% 7.4% 10.5% 13.2% 14.2% 15.5% 14.0% 10.1%

    Stage 3 18.7% 25.1% 35.7% 50.9% 49.0% 44.9% 38.3% 30.3% 21.0% 16.4%

    Stage 2 40.0% 37.2% 31.4% 16.9% 14.6% 12.4% 10.7% 7.6% 5.1% 2.6%

    Stage 1 17.4% 14.0% 11.5% 7.2% 7.1% 5.7% 4.3% 3.3% 2.0% 1.7%

    Stage 0 20.4% 19.3% 15.6% 11.5% 10.1% 9.0% 8.4% 5.8% 3.7% 2.1%

    N = 4,237 N = 5,073 N = 5,166 N = 5,281 N = 5,337 N = 5,458 N = 5,458 N = 5,449 N = 5,467 N = 5,460

    Data from HIMSS Analytics® Database ©

    This is how long it takes to make “significant” national progress

  • Cross Regional EMRAM Score Distribution# (2015)

    Stage Asia Pacific Middle East United States Canada Europe*

    Stage 7 0.5% 0.0% 4.2% 0.2% 0.1%

    Stage 6 3.9% 11.3% 27.1% 0.9% 4.6%

    Stage 5 7.4% 21.1% 35.9% 3.4% 17.5%

    Stage 4 1.7% 3.5% 10.1% 1.6% 5.5%

    Stage 3 0.6% 19.0% 16.4% 31.2% 3.2%

    Stage 2 32.7% 19.0% 2.6% 31.5% 30.2%

    Stage 1 4.9% 9.9% 1.7% 13.9% 14.2%

    Stage 0 48.2% 16.2% 2.1% 17.3% 24.1%

    N = 770 N = 142 N = 5,460 N = 641 N = 2,395

    Data from HIMSS Analytics® Database ©

  • Belgium, Brazil, Canada, Chile, China, Denmark, France , Germany, India, Italy, Malaysia, Netherlands, Norway, Saudi Arabia, Singapore, Switzerland, Taiwan, Turkey, UAE, UK, USA

    China, Korea, Germany, Saudi Arabia, Spain, USA

  • Benefits realization from IT

    HIMSS Analytics Database® correlation studies with other comprehensive data sources.

  • Profile of a Stage 7 Organization • Use data to drive improved outcomes related to …

    – Process, Financial, Clinical, Quality & Safety

    • Are paperless, or near paperless (create no paper) – All clinically relevant data is in the EMR

    • Are fully committed to continuous process improvement

    through collaboration – Strong IT leadership and executive champions – Clinician / end-user champions

  • Representation of TJC Top Performing Hospitals BY Number of Quality Metrics Excelling In, within each EMRAM Stage

    1.9% 4.8%

    10.1% 8.1% 4.2% 6.5%

    7.9% 9.7% 0.4% 1.7%

    6.2% 10.0%

    6.4% 6.4%

    12.8%

    30.1%

    0%

    10%

    20%

    30%

    40%

    50%

    Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 6 Stage 7

    All h

    ospi

    tals

    with

    in ea

    ch E

    MRAM

    Sta

    ge

    3 or less 4 or more Source: HIMSS Analytics

    2.3% 6.5%

    16.3% 18.1%

    10.6% 12.9%

    20.7%

    39.8%

  • Representation of Hospitals with an "A" Leapfrog Hospital Safety Grade by EMRAM Stage

    0.0% 5.9%

    12.8% 14.3% 20.1% 21.8%

    30.8%

    62.6%

    0%

    10%

    20%

    30%

    40%

    50%

    60%

    70%

    Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 6 Stage 7

    All h

    ospi

    tals

    with

    in ea

    ch E

    MRAM

    Sta

    ge

    Source: HIMSS Analytics

  • 38.9

    45.5 44.6 45.9 45.9 42.7

    49.0

    64.3

    30

    40

    50

    60

    70

    Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 6 Stage 7

    AVG

    Pro

    ject

    ed V

    BP

    Clin

    ical

    Sco

    re

    Tipping Point

    Tipping Point

    Clinical Performance

    Source: HIMSS Analytics

  • Mortality Rates

    0%

    10%

    20%

    30%

    Heart Atack Respiratory Therapy

    Actual MortalityLow EMRAM

    Actual MortalityHigh EMRAM

    Source: HIMSS Analytics

  • -1.52%

    4.91%

    -0.43%

    6.19%

    2.77%

    7.95%

    -2.0%

    0.0%

    2.0%

    4.0%

    6.0%

    8.0%

    10.0%

    Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Stage 6 Stage 7

    Aver

    age

    Ope

    ratin

    g M

    argi

    n

    In 2011 In 2013 In 2015

    Financial Performance (Profitability)

    Data from HIMSS Analytics® Database ©

    Source: HIMSS Analytics

  • Stage 7 Case Studies

    Actual case studies from validated Stage 7 hospitals

  • Medication Administration Errors per 1000 CMI-Adjusted Pt Days

    0

    0.05

    0.1

    0.15

    0.2

    0.25

    0.3

    0.35

    0.4

    0.45

    0.5

    Jan 2011 Jan 2013 Jun 2013

    7 10

    Pt Scan: 96% Med Scan 93%

    Pt Scan: 79% Med Scan: 76%

    44% 62%

    19

  • Annual Incident Reports 2009 – 2013* per 1000 CMI-Adjusted Pt Days

    0

    0.5

    1

    1.5

    2

    2.5

    0

    5

    10

    15

    20

    25

    2009 2010 2011 2012 2013*

    Med

    icat

    ion

    Even

    ts

    Oth

    er In

    cide

    nt R

    epor

    ts

    Other Incident Reports Medication Events

  • Annual Incident Reports 2009 – 2013* per 1000 CMI-Adjusted Pt Days

    0

    0.02

    0.04

    0.06

    0.08

    0.1

    0

    0.5

    1

    1.5

    2

    2.5

    2009 2010 2011 2012 2013*

    Sign

    ifica

    nt A

    DE

    Med

    icat

    ion

    Even

    ts

    Medication Events Significant ADE

  • 30

    20

    4 0

    5.34

    4.47

    1.08

    0.00 0

    10

    20

    30

    40

    50

    60

    0.00

    1.00

    2.00

    3.00

    4.00

    5.00

    6.00

    Jul 10 to Jun 11 Jul 11 to Jun 12 Jul 12 to Jun 13 Jul 13 to Sep 13 (3months)

    # C

    AU

    TI

    Rat

    e pe

    r 100

    0 ca

    thet

    er-d

    ays

    Catheter-Associated Urinary Tract Infection (CAUTI) rate per 1000 catheter-days

    # CAUTI CAUTI rate per 1000 catheter-days

  • Central Line-associated bloodstream infection (CLABSI)

  • Human (breast) milk administration through CLMA process

  • % Antibiotics given within one hour

    Attention to detail Some changes in the

    pharmacy Reduction in the number

    of unnecessary STAT orders

    Great communication by the team

  • • Grid/Order Set Form Approach for Chemotherapy • Reduced CPOE from 90 Minutes to 15 Minutes per Patient

    Order Sets Process Improvement

  • Questions

    THANK YOU John H. Daniels, CNM, FHIMSS, FACHE, CPHIMS Global Vice President, Healthcare Advisory Services Group [email protected]

    @JohnHDaniels

    mailto:[email protected]:[email protected]:[email protected]

    Healthcare IT Adoption, Function, Value & Beyond�February 29, 2016AgendaLearning ObjectivesSlide Number 4Slide Number 5Information technology is a MUSTUltimate GoalHow can we do this?Shared VisionSlide Number 10HIMSS’ contribution to the visionIt takes time to make “significant” national progressSlide Number 13Slide Number 14Slide Number 15Slide Number 16Slide Number 17Slide Number 18Slide Number 19Slide Number 20Slide Number 21Slide Number 22Slide Number 23Slide Number 24Slide Number 25Benefits realization from ITProfile of a Stage 7 OrganizationRepresentation of TJC Top Performing Hospitals BY Number of Quality Metrics Excelling In, within each EMRAM Stage Representation of Hospitals with an "A" Leapfrog Hospital Safety Grade by EMRAM Stage�Clinical Performance Mortality RatesFinancial Performance �(Profitability)Stage 7 Case StudiesMedication Administration Errors�per 1000 CMI-Adjusted Pt DaysAnnual Incident Reports 2009 – 2013* �per 1000 CMI-Adjusted Pt DaysAnnual Incident Reports 2009 – 2013*�per 1000 CMI-Adjusted Pt DaysSlide Number 37Slide Number 38Slide Number 39Slide Number 40Slide Number 41Slide Number 42Slide Number 43Slide Number 44Slide Number 45Slide Number 46% Antibiotics given within one hourOrder Sets Process ImprovementQuestions